MALIN CORP PLC (MLC.I) Stock Overview
Europe - DUB:MLC - IE00BVGC3741 - Common Stock
MLC.I Key Statistics, Chart & Performance
The current stock price of MLC.I is 8.65 EUR. In the past month the price increased by 8.13%. In the past year, price increased by 49.14%.
MLC.I Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TN8.DE | THERMO FISHER SCIENTIFIC INC | 24.65 | 174.63B | ||
| 1DHR.MI | DANAHER CORP | 28.53 | 131.68B | ||
| DAP.DE | DANAHER CORP | 27.57 | 127.31B | ||
| LO3.DE | LONZA GROUP AG-REG | 34.89 | 40.78B | ||
| QTS.DE | IQVIA HOLDINGS INC | 18.15 | 30.33B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 47.7 | 19.17B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 46.73 | 18.78B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 49.95 | 16.27B | ||
| SRT.DE | SARTORIUS AG | 41.1 | 13.39B | ||
| ILU.DE | ILLUMINA INC | 23.36 | 12.82B | ||
| ESF0.DE | EUROFINS SCIENTIFIC | 17.31 | 11.35B | ||
| ERF.PA | EUROFINS SCIENTIFIC | 17.31 | 11.35B |
Related stock screener links
About MLC.I
Company Profile
Malin Corp. Plc.invests and supports innovative life sciences companies, which develops exceptional science and technology to deliver transformative outcomes for patients. The company is headquartered in Dublin, Dublin and currently employs 2 full-time employees. The company went IPO on 2015-03-25. The Company’s assets give investors access to life sciences businesses with exposure across diverse modalities, therapeutic areas and geographies. Its business includes Poseida, Viamet, Xenex, WaveBreak, KNOW Bio, and Artizan. Poseida is a clinical-stage biopharmaceutical company building a pipeline of Chimeric antigen receptor T cell (CAR-T) product candidates. Xenex is a commercial-stage medical device company focused on reducing healthcare-associated infections with its non-mercury, full-spectrum disinfection LightStrike Germ-Zapping robots. KNOW Bio is a life science company engaged in the fields of nitric oxide and precision light therapy. WaveBreak Therapeutics company focuses on the development of medicines for the treatment of protein-misfolding diseases including Alzheimer's and Parkinson's. Artizan is a biotechnology company.
Company Info
MALIN CORP PLC
The Lennox Building, 50 Richmond Street South
DUBLIN DUBLIN IE
Employees: 2
Phone: 35319015700
MALIN CORP PLC / MLC.I FAQ
What is the stock price of MALIN CORP PLC today?
The current stock price of MLC.I is 8.65 EUR. The price increased by 5.49% in the last trading session.
What is the ticker symbol for MALIN CORP PLC stock?
The exchange symbol of MALIN CORP PLC is MLC and it is listed on the Euronext Dublin exchange.
On which exchange is MLC.I stock listed?
MLC.I stock is listed on the Euronext Dublin exchange.
What is the price forecast or stock price prediction for MALIN CORP PLC stock?
5 analysts have analysed MLC.I and the average price target is 15.81 EUR. This implies a price increase of 82.77% is expected in the next year compared to the current price of 8.65. Check the MALIN CORP PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MALIN CORP PLC worth?
MALIN CORP PLC (MLC.I) has a market capitalization of 37.45M EUR. This makes MLC.I a Nano Cap stock.
How many employees does MALIN CORP PLC have?
MALIN CORP PLC (MLC.I) currently has 2 employees.
What are the support and resistance levels for MALIN CORP PLC (MLC.I) stock?
MALIN CORP PLC (MLC.I) has a support level at 8.09 and a resistance level at 8.66. Check the full technical report for a detailed analysis of MLC.I support and resistance levels.
Should I buy MALIN CORP PLC (MLC.I) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MLC.I, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MLC.I, evaluating the profitability, health, valuation and growth aspects
- MALIN CORP PLC (MLC.I) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MALIN CORP PLC (MLC.I) Sales and EPS estimates to see what analysts future expectations are.
- MALIN CORP PLC (MLC.I) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MALIN CORP PLC (MLC.I) Insider and Institutional Ownership to learn about the owners and their transactions.
- MALIN CORP PLC (MLC.I) Stock Chart to make your own analysis
- MALIN CORP PLC (MLC.I) Latest news and press-releases to stay up to date.
Does MALIN CORP PLC (MLC.I) stock pay dividends?
MLC.I does not pay a dividend.
When does MALIN CORP PLC (MLC.I) report earnings?
MALIN CORP PLC (MLC.I) will report earnings on 2026-02-17.
MLC.I Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to MLC.I. When comparing the yearly performance of all stocks, MLC.I is one of the better performing stocks in the market, outperforming 82.4% of all stocks.
MLC.I Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MLC.I Forecast & Estimates
5 analysts have analysed MLC.I and the average price target is 15.81 EUR. This implies a price increase of 82.77% is expected in the next year compared to the current price of 8.65.